These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32126476)

  • 41. High-sensitivity C-reactive protein and high mobility group box-1 levels in Parkinson's disease.
    Baran A; Bulut M; Kaya MC; Demirpençe Ö; Sevim B; Akıl E; Varol S
    Neurol Sci; 2019 Jan; 40(1):167-173. PubMed ID: 30353300
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-high mobility group box-1 monoclonal antibody protects the blood-brain barrier from ischemia-induced disruption in rats.
    Zhang J; Takahashi HK; Liu K; Wake H; Liu R; Maruo T; Date I; Yoshino T; Ohtsuka A; Mori S; Nishibori M
    Stroke; 2011 May; 42(5):1420-8. PubMed ID: 21474801
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tonic phase of a generalized convulsive seizure is an independent predictor of postictal generalized EEG suppression.
    Tao JX; Yung I; Lee A; Rose S; Jacobsen J; Ebersole JS
    Epilepsia; 2013 May; 54(5):858-65. PubMed ID: 23360300
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical utility of serum lactate levels for differential diagnosis of generalized tonic-clonic seizures from psychogenic nonepileptic seizures and syncope.
    Doğan EA; Ünal A; Ünal A; Erdoğan Ç
    Epilepsy Behav; 2017 Oct; 75():13-17. PubMed ID: 28806632
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased Serum HMGB-1, ICAM-1 and Metalloproteinase-9 Levels in Buerger's Patients.
    De Caridi G; Bitto A; Massara M; Pallio G; Pizzino G; Serra R; Altavilla D; Squadrito F; Spinelli F
    Curr Vasc Pharmacol; 2016; 14(4):382-7. PubMed ID: 26935815
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Postictal breathing pattern distinguishes epileptic from nonepileptic convulsive seizures.
    Azar NJ; Tayah TF; Wang L; Song Y; Abou-Khalil BW
    Epilepsia; 2008 Jan; 49(1):132-7. PubMed ID: 17651411
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High Mobility Group Box 1 is a novel pathogenic factor and a mechanistic biomarker for epilepsy.
    Ravizza T; Terrone G; Salamone A; Frigerio F; Balosso S; Antoine DJ; Vezzani A
    Brain Behav Immun; 2018 Aug; 72():14-21. PubMed ID: 29031614
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Kaempferol Attenuates LPS-Induced Striatum Injury in Mice Involving Anti-Neuroinflammation, Maintaining BBB Integrity, and Down-Regulating the HMGB1/TLR4 Pathway.
    Yang YL; Cheng X; Li WH; Liu M; Wang YH; Du GH
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30678325
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High-mobility group box 1 (HMGB1) crosses the BBB bidirectionally.
    Banks WA; Hansen KM; Erickson MA; Crews FT
    Brain Behav Immun; 2023 Jul; 111():386-394. PubMed ID: 37146655
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A comparison of high-mobility group-box 1 protein, lipopolysaccharide-binding protein and procalcitonin in severe community-acquired infections and bacteraemia: a prospective study.
    Gaïni S; Koldkjaer OG; Møller HJ; Pedersen C; Pedersen SS
    Crit Care; 2007; 11(4):R76. PubMed ID: 17625012
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of HMGB1 and RAGE in rat and human brains after traumatic brain injury.
    Gao TL; Yuan XT; Yang D; Dai HL; Wang WJ; Peng X; Shao HJ; Jin ZF; Fu ZJ
    J Trauma Acute Care Surg; 2012 Mar; 72(3):643-9. PubMed ID: 22491548
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preliminary study of high mobility group box chromosomal protein 1(HMGB1) in ankylosing spondylitis patients.
    Chen Y; Sun W; Li S; Ni J; Su Y; Wang C; Luo X; Tu W; Shen G; Gong F; Zheng F; Dong L
    Clin Exp Rheumatol; 2015; 33(2):187-94. PubMed ID: 25602579
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HMGB1 Release Induced by EV71 Infection Exacerbates Blood-Brain Barrier Disruption via VE-cadherin Phosphorylation.
    You Q; Wu J; Liu Y; Zhang F; Jiang N; Tian X; Cai Y; Yang E; Lyu R; Zheng N; Chen D; Wu Z
    Virus Res; 2023 Dec; 338():199240. PubMed ID: 37832655
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-high mobility group box protein 1 monoclonal antibody downregulating P-glycoprotein as novel epilepsy therapeutics.
    de Liyis BG; Tandy SG; Endira JF; Putri KA; Utami DKI
    Egypt J Neurol Psychiatr Neurosurg; 2022; 58(1):121. PubMed ID: 36310854
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ictal Symmetric Tonic Extension Posturing and Postictal Generalized EEG Suppression Arising From Sleep in Children With Epilepsy.
    Okanari K; Otsubo H; Kouzmitcheva E; Rangrej J; Baba S; Ochi A; Okanishi T; Homma Y; Nita DA; Donner EJ
    Pediatr Neurol; 2017 Nov; 76():54-59. PubMed ID: 28967460
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HMGB1-RAGE Signaling Plays a Role in Organic Dust-Induced Microglial Activation and Neuroinflammation.
    Massey N; Puttachary S; Bhat SM; Kanthasamy AG; Charavaryamath C
    Toxicol Sci; 2019 Jun; 169(2):579-592. PubMed ID: 30859215
    [TBL] [Abstract][Full Text] [Related]  

  • 57. C-reactive protein and seizures in focal epilepsy: a video-electroencephalographic study.
    Alapirtti T; Waris M; Fallah M; Soilu-Hänninen M; Mäkinen R; Kharazmi E; Peltola J
    Epilepsia; 2012 May; 53(5):790-6. PubMed ID: 22462619
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chronic cerebral hypoperfusion-induced impairment of Aβ clearance requires HB-EGF-dependent sequential activation of HIF1α and MMP9.
    Ashok A; Rai NK; Raza W; Pandey R; Bandyopadhyay S
    Neurobiol Dis; 2016 Nov; 95():179-93. PubMed ID: 27431094
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Changes in serum miRNAs following generalized convulsive seizures in human mesial temporal lobe epilepsy.
    Surges R; Kretschmann A; Abnaof K; van Rikxoort M; Ridder K; Fröhlich H; Danis B; Kaminski RM; Foerch P; Elger CE; Weinsberg F; Pfeifer A
    Biochem Biophys Res Commun; 2016 Dec; 481(1-2):13-18. PubMed ID: 27833019
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dysfunction of the blood-brain barrier in postoperative delirium patients, referring to the axonal damage biomarker phosphorylated neurofilament heavy subunit.
    Mietani K; Sumitani M; Ogata T; Shimojo N; Inoue R; Abe H; Kawamura G; Yamada Y
    PLoS One; 2019; 14(10):e0222721. PubMed ID: 31574089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.